骨架缓释片,matrix sustained release tablets
1)matrix sustained release tablets骨架缓释片
英文短句/例句
1.Formula and Preparation Technology of Gel Matrix Sustained Release Tablet of Nicotinic Acid烟酸凝胶骨架缓释片的处方工艺研究
2.Studies on the Factors Influencing Oleanolic Acid Release from Matrix Tablets齐墩果酸骨架缓释片释药影响因素的考察
3.Design and Evaluation of Gel Matrix Sustained Release Tablet of Gliclazide;格列齐特凝胶骨架缓释片的设计与评价
4.The Study of Ferrous Fumarate Hydrogel Matrix Sustained Release Tablets;富马酸亚铁亲水凝胶骨架缓释片的研究
5.Determination of Metoprolol tartrate sustained-release matrix tablets by HPLCHPLC法测定酒石酸美托洛尔骨架缓释片的含量
6.Preparation of sustained-release total alkaloids tablets of Runus alceaefolius Poir and its release property in vitro粗叶悬钩子总生物碱骨架缓释片的制备及体外释放特性
7.Progress on Evaluation Methods for Release Mechanism of Hydrophlic Gel Matrix Sustained-Release Tablets亲水凝胶骨架缓释片释药机制评价方法的研究进展
8.Research and Preparation of HPMC-Based Matrix Sustained Release Tablets of Artificial Musk;人工麝香骨架缓释双层片制剂学研究
9.Studies on the Application of Konjac Glucomannan as the Carrier Materials in Sustained Release Matrix Tablet;魔芋胶作为缓释骨架片载体材料应用的研究
10.Study on Hydrophilic Gel Matrix Sustained-release Tablets of Rosiglitazone Maleate马来酸罗格列酮亲水凝胶缓释骨架片的研究
11.Preparation and phamacokinetics of sustained-release dosage form of naproxen sodium萘普生钠缓释骨架片的制备及药动学研究
12.Preparation of coated levalbuterol hydrochloride matrix sustained-released tablet左旋盐酸沙丁胺醇凝胶骨架包衣缓释片的制备
13.Preparation and Release of Minocycline Hydrophilic Gel Sustained-release Matrix Tablets米诺环素亲水凝胶型缓释骨架片的制备及体外释放度考察
14.The Preparation of Safflower Yellow Sustained-release Matrix Tablets and Their Drug Release in Vitro红花黄色素缓释骨架片的研制及其体外释放度的研究
15.Effect of formulation and technology on drug release mechanism of puerarin gel matrix sustained-release tablets处方工艺对葛根素羟丙甲纤维素缓释骨架片体外释药机制的影响
16.Study on Glipizide Semisolid-Matrix Sustained-Release Capsules;半固体骨架型格列吡嗪缓释胶囊的研制
17.Design and Evaluation of Martrix Sustained Release Pellets of Breviscapin;中药灯盏花素骨架缓释微丸的设计与评价
18.Factors Influencing the Release of Potassium Citrate Gel Matrix Sustained-release Pill in Vitro枸橼酸钾凝胶骨架缓释丸体外释放的影响因素研究
相关短句/例句
sustained-release matrix tablets缓释骨架片
1.Study on preparation of the metformin hydrochloridesustained-release matrix tablets;盐酸二甲双胍缓释骨架片的研制
3)hidrophilic matrix sustained-release tablets凝胶骨架缓释片
1.Preparation and in vitro dissolution of stachydrine hydrochloridehidrophilic matrix sustained-release tablets;盐酸水苏碱凝胶骨架缓释片的研制与体外释放评价
4)matrix tablets骨架型缓控释片
1.New progress on research of the sustained and controlled releasematrix tablets;骨架型缓控释片研究的新进展
5)matrix sustained release tablet骨架缓释片剂
6)matrix sustained-release tablets肠溶骨架缓释片
延伸阅读
茶碱缓释片，无水茶碱缓释片，茶碱, 埃斯玛隆药物名称：茶碱英文名：Theophylline别名：茶碱缓释片，无水茶碱缓释片，茶碱, 埃斯玛隆；葆乐辉；时乐平；舒弗美 ，优喘平，长效茶喘平外文名：Theophylline Sustained Release Tablets(茶碱缓释片),Anhydrous Theophylline Sustained Tablets(无水茶碱缓释片),ASMALON, Elixophylline, Etrafon, Theo-Dur, PROTHEO成分： 茶碱 适应症： 支气管哮喘以及伴有慢性支气管炎和肺气肿的可逆性支气管痉挛，对夜间发作的哮喘患者更适宜。 用量用法： 成人 一般剂量为200mg/日，晚上8－9点服用或早晚各服用100mg,根据病情可增加剂量至最大用量600mg/日，3岁以上儿童10mg/kg体重/日。 禁忌： 对茶碱不能耐受的病人，未治愈的癫痫患者。 不良反应： 头痛、恶心、失眠，少见消化不良、震颤和眩晕。 注意事项： 消化性溃疡，肝肾功能不全，心力衰竭，持续高烧及使用某些药物，有低氧血症，高血压病史的患者慎用。孕妇及哺乳妇女避免使用。茶碱的毒性常出现在血清浓度为１５～２０μｇ/ｍｌ，特别是在治疗开始，早期多见的有恶心、呕吐、易激动、失眠等，当血清浓度超过２０μｇ/ｍｌ，可出现心动过速、心律失常，血清中茶碱超过４０μｇ/ｍｌ，可发生发热、失水、惊厥等症状，严重的甚至呼吸、心跳停止致死。本品可通过胎盘屏障，也能分泌入乳汁，随乳汁排出，故孕妇、产妇及哺乳期妇女慎用。新生儿血浆清除率可降低，血清浓度增加，应慎用。老年人因血浆清除率降低，潜在毒性增加，５５岁以上患者慎用。 药物相互作用： 与别嘌呤醇，西咪替丁，环丙沙星，红霉素及口服避孕药合用，可使茶碱血浓度增加。与利福平合用时，可使血清浓度降低。与苯妥因合用时，二者血药浓度均降低。勿与非选择性β－受体阻滞剂同时使用。 规格： 胶囊 50 mg x 10粒。100 mg x 10粒。200mg x 10粒。 类别：平喘药\磷酸二酯酶抑制药
